SCHEMBL14850480

SCHEMBL14850480

C=CC[C@](C)(C(=O)O)c1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.62
▸ TSHR P16473 1/20 0.62
▸ HTT P42858 1/20 0.54
▸ KMT2A Q03164 3/20 0.47
▸ SMN1; SMN2 Q16637 3/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ CYP2C19 P33261 3/20 0.44
▸ HIF1A Q16665 1/20 0.44
▸ MAPT P10636 3/20 0.44
▸ CYP1A2 P05177 2/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ HDAC3 O15379 1/20 0.39
▸ HDAC4 P56524 1/20 0.39
▸ HDAC1 Q13547 1/20 0.39
▸ HDAC7 Q8WUI4 1/20 0.39
▸ HDAC2 Q92769 1/20 0.39
▸ HDAC10 Q969S8 1/20 0.39
▸ HDAC11 Q96DB2 1/20 0.39
▸ HDAC8 Q9BY41 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2927687 1.00 ALDH1A1 (0.62) ALDH1A1TSHRHTTKMT2ASMN1; SMN2
SCHEMBL6751634 0.86 ALDH1A1 (0.55) ALDH1A1TSHRHTTKMT2ASMN1; SMN2
SCHEMBL29098857 0.86 ALDH1A1 (0.54) ALDH1A1TSHRHTTKMT2ASMN1; SMN2
SCHEMBL27266784 0.82 ALDH1A1 (0.47) ALDH1A1TSHRHTTKMT2ASMN1; SMN2
SCHEMBL31625977 0.82 ALDH1A1 (0.47) ALDH1A1TSHRHTTKMT2ASMN1; SMN2
SCHEMBL29336758 0.82 ALDH1A1 (0.50) ALDH1A1TSHRHTTKMT2ASMN1; SMN2
SCHEMBL15848349 0.82 ALDH1A1 (0.50) ALDH1A1TSHRHTTKMT2ASMN1; SMN2
SCHEMBL12323847 0.80 ALDH1A1 (0.45) ALDH1A1TSHRHTTKMT2ASMN1; SMN2
SCHEMBL10983149 0.80 CA9 (0.48) ALDH1A1TSHRKMT2AMEN1KDM4E
SCHEMBL4001984 0.80 ALDH1A1 (0.43) ALDH1A1TSHRHTTKMT2ACYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013052362-A1 HEPATITIS C VIRUS INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2013-04-11 — — WO disclosed
Send feedback